We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » US PRO Instrument Guidance Requires Patient Input
US PRO Instrument Guidance Requires Patient Input
December 17, 2009
After three years of comment review, the U.S. Food and Drug Administration (FDA) has issued a final guidance on patient-reported outcome (PRO) instruments
submitted in applications.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor